Published in Gene Therapy Weekly, December 21st, 2006
"We are enthusiastic about this target, especially as there has been positive proof of concept data in experimental animal models," said Lisa N. Drakeman, PhD, chief executive officer of Genmab.
Denny Willson, president and CEO of Cytokine PharmaSciences, stated, "Genmab is a world-class company in the area of developing human antibody therapeutics. We are pleased to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.